These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20078866)

  • 21. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
    Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
    Xu C; Zhou T; He M; Sun Y
    Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions.
    El Sharkawy SL; Abbas NF; Badawi MA; El Shaer MA
    J Clin Pathol; 2006 Nov; 59(11):1171-4. PubMed ID: 16574721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prostatic specific antigen (PS), pro-inflammatory cytokines, and prostatic pathology (benign prostatic hyperplasia and cancer). Relationship with malignancy].
    Cansino Alcaide JR; Vera San Martín R; Rodríguez de Bethencourt Codes F; Bouraoui Y; Rodríguez Berriguete G; Oueslati R; Pérez-Utrilla M; De la Peña Barthel J; Paniagua Gómez-Alvarez R; Royuela García M
    Arch Esp Urol; 2009 Jun; 62(5):359-66. PubMed ID: 19721171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoexpression of tumour necrosis factor-alpha and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostate.
    de Miguel MP; Royuela M; Bethencourt FR; Santamaría L; Fraile B; Paniagua R
    Cytokine; 2000 May; 12(5):535-8. PubMed ID: 10857774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
    Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
    Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expressions of TFF1 and TFF3 in prostate cancer and prostatic intraepithelial neoplasia and their clinical significance].
    Liu M; Jin RS
    Zhonghua Nan Ke Xue; 2015 Apr; 21(4):315-9. PubMed ID: 26027097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
    Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
    Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Pan CX; Kinch MS; Kiener PA; Langermann S; Serrero G; Sun L; Corvera J; Sweeney CJ; Li L; Zhang S; Baldridge LA; Jones TD; Koch MO; Ulbright TM; Eble JN; Cheng L
    Clin Cancer Res; 2004 Feb; 10(4):1333-7. PubMed ID: 14977833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
    Cardillo MR; Ippoliti F
    Anticancer Res; 2006; 26(5A):3409-16. PubMed ID: 17094460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer.
    Segawa Y; Yoshimura R; Hase T; Nakatani T; Wada S; Kawahito Y; Kishimoto T; Sano H
    Prostate; 2002 May; 51(2):108-16. PubMed ID: 11948965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma.
    Ricote M; Royuela M; García-Tuñón I; Bethencourt FR; Paniagua R; Fraile B
    J Urol; 2003 Sep; 170(3):787-90. PubMed ID: 12913698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of NF-κBp(65/NFκBp50) among prostate specific antigen sera levels in prostatic pathologies.
    Bouraoui Y; Ben Jemaa A; Rodriguez G; Ben Rais N; Fraile B; Paniagua R; Sellemi S; Royuela M; Oueslati R
    Pathol Biol (Paris); 2012 Oct; 60(5):301-5. PubMed ID: 21889270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody.
    Zhang PJ; Driscoll DL; Lee HK; Nolan C; Velagapudi SR
    Hum Pathol; 1999 Feb; 30(2):168-72. PubMed ID: 10029444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.